OBJECTIVE: To evaluate the cardiopulmonary effects of two different constant rate infusions (CRI) of dexmedetomidine (1 and 1.75 microg kg(-1 )hour(-1)) in experimental ponies. ANIMALS: Six healthy ponies (mean 306 +/- SD 71 kg, 7.0 +/- 1.6 years). STUDY DESIGN: Prospective, randomized, experimental study. METHODS: After premedication with intravenous (IV) dexmedetomidine (3.5 microg kg(-1)), anaesthesia was induced (T0) with ketamine (2.2 mg kg(-1) IV) and midazolam (0.06 mg kg(-1) IV) and maintained with isoflurane (Fe'ISO 1.50%) in 55% oxygen for 150 minutes. Normocapnia was maintained using artificial ventilation. Three ponies received dexmedetomidine CRIs of 1 and 1.75 microg kg(-1 )hour(-1) from T30 to T60 and T90 to T120 respectively. In the other three ponies, the order of the doses was reversed. Continuous monitoring included pulse oximetry, electrocardiography, anaesthetic gas monitoring, arterial and central venous pressures. Cardiac output (LiDCO technique) was measured and arterial and venous bloods taken every 15 minutes. Cardiac index (CI), systemic vascular resistance (SVR), arterial and venous oxygen content (CaO(2), CvO(2)) and oxygen delivery (DO(2)) were calculated. Analysis of variance with separate models for each CRI rate was used to detect differences between values obtained at the end of the CRI and their respective baseline values. A mixed model with these differences as response variable, pony as random effect and treatment and period as fixed effects was applied to find differences between the two CRIs (alpha = 0.05 for all analyses). RESULTS: Heart rate (HR), CI, CaO(2), CvO(2) and DO(2) decreased significantly, while significant increases were found in SVR, systolic arterial pressure and right atrial pressure with both infusion rates. No differences were found between the two dexmedetomidine CRI rates. CONCLUSIONS AND CLINICAL RELEVANCE: Although significant, cardiopulmonary effects of the dexmedetomidine CRIs in isoflurane anaesthetized ponies were small, without differences between the two dose rates.
OBJECTIVE: To evaluate the cardiopulmonary effects of two different constant rate infusions (CRI) of dexmedetomidine (1 and 1.75 microg kg(-1 )hour(-1)) in experimental ponies. ANIMALS: Six healthy ponies (mean 306 +/- SD 71 kg, 7.0 +/- 1.6 years). STUDY DESIGN: Prospective, randomized, experimental study. METHODS: After premedication with intravenous (IV) dexmedetomidine (3.5 microg kg(-1)), anaesthesia was induced (T0) with ketamine (2.2 mg kg(-1) IV) and midazolam (0.06 mg kg(-1) IV) and maintained with isoflurane (Fe'ISO 1.50%) in 55% oxygen for 150 minutes. Normocapnia was maintained using artificial ventilation. Three ponies received dexmedetomidine CRIs of 1 and 1.75 microg kg(-1 )hour(-1) from T30 to T60 and T90 to T120 respectively. In the other three ponies, the order of the doses was reversed. Continuous monitoring included pulse oximetry, electrocardiography, anaesthetic gas monitoring, arterial and central venous pressures. Cardiac output (LiDCO technique) was measured and arterial and venous bloods taken every 15 minutes. Cardiac index (CI), systemic vascular resistance (SVR), arterial and venous oxygen content (CaO(2), CvO(2)) and oxygen delivery (DO(2)) were calculated. Analysis of variance with separate models for each CRI rate was used to detect differences between values obtained at the end of the CRI and their respective baseline values. A mixed model with these differences as response variable, pony as random effect and treatment and period as fixed effects was applied to find differences between the two CRIs (alpha = 0.05 for all analyses). RESULTS: Heart rate (HR), CI, CaO(2), CvO(2) and DO(2) decreased significantly, while significant increases were found in SVR, systolic arterial pressure and right atrial pressure with both infusion rates. No differences were found between the two dexmedetomidine CRI rates. CONCLUSIONS AND CLINICAL RELEVANCE: Although significant, cardiopulmonary effects of the dexmedetomidine CRIs in isoflurane anaesthetized ponies were small, without differences between the two dose rates.
Authors: Mohammad Reza Esmailinejad; Majid Masoudifard; Omid Azari; Ehsanollah Sakhaee; Nima Ghalekhani Journal: Vet Res Forum Date: 2022-03-15 Impact factor: 0.950
Authors: Vanessa Rabbogliatti; Martina Amari; Federica Alessandra Brioschi; Federica Di Cesare; Davide Danilo Zani; Donatella De Zani; Mauro Di Giancamillo; Petra Cagnardi; Giuliano Ravasio Journal: BMC Vet Res Date: 2022-07-11 Impact factor: 2.792